Funding for this research was provided by:
Novo Nordisk Fonden (NNF17SA0027784, NNF17SA027784)
Article History
Received: 29 August 2019
Accepted: 13 March 2020
First Online: 7 April 2020
Competing interests
: I.G.C. has served as a consultant for Otsuka Pharmaceutical on their Abilify MyCite product. The company neither funded the preparation of this article nor played a role in its drafting or review.